is tirzepatide approved for sleep apnea FDA Approves First Drug Tirzepatide, also known as Mounjaro

Reflux causes esophageal irritation that triggers more nausea

The first reason is that it is not guaranteed to work anymore and could seriously impact the efficacy of your diabetes or weight-loss treatment

Sources Blum, D

Wong and colleagues applied body mass index and other risk factor changes to cardiovascular disease risk scores among an estimated 83 million persons without pre-existing cardiovascular disease, estimating a reduction in 10-year cardiovascular disease risk of 1.8% from 10.15% to 8.34% (or a relative risk reduction of 18%), projecting up to 1.5 million cardiovascular events could be potentially prevented in 10 years